0000-0002-9264-9549 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (25)
- Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab Save
- Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment Save
- Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials Save
- Low expression of TMPRSS2-a SARS-CoV-2 internalization protease-associates with basal subtype of head and neck squamous cell carcinoma. Save
- Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants Save
- Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors Save
- Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors Save
- Identification and Evaluation of Apoptosis-Inducing Activity of Ipomone from Ipomoea nil: A Novel, Unusual Bicyclo-[3.2.1] Octanone Containing Gibberic Acid Diterpenoid Save
- Immune profiles in primary squamous cell carcinoma of the head and neck. Save
- Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer. Save